Stryker has completed the acquisition of Vertos Medical, a developer of interventional pain management solutions for chronic lower back pain caused by lumbar spinal stenosis.
 
Vertos’ FDA-cleared mild procedure offers a pain relief solution and can improve mobility without needing major surgery, the company said. The procedure addresses a root cause of lumbar spinal stenosis by removing excess ligament tissue to restore space in the canal. The procedure usually takes less than an hour and can be performed through a single incision smaller than the size of a baby aspirin (5.1 mm).
 
mild is a potential early treatment option when conservative therapies like physical therapy, pain medication, and chiropractic treatments do not provide adequate relief. It’s covered by Medicare and Medicare Advantage plans nationwide, as well.
 
“The acquisition of Vertos Medical enhances our unique, non-surgical solutions for interventionalists addressing chronic lower back pain, while broadening our presence in ambulatory surgery centers,” said Andy Pierce, Group President, MedSurg and Neurotechnology, Stryker. “We look forward to enabling physicians with the minimally invasive mild procedure so patients can reclaim their quality of life.”